Precision BioSciences, Inc. (DTIL) Stock: Why It’s Falling

0

Precision BioSciences, Inc. (DTIL) is falling in the market today. The stock, focused on the biotech space, is currently trading at $12.78 after falling -5.89% so far in today’s session. When it comes to biotechnology stocks, there are several factors that have the ability to cause price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines centered around DTIL:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-24-19 06:30AM Precision BioSciences Announces Presentations at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy
Apr-17-19 05:30AM Precision BioSciences Announces Dosing of First Patient in Off-The-Shelf CAR T Cell Therapy Phase 1/2a Clinical Trial
Apr-04-19 01:55PM A Fidelity-Affiliated VC Fund Has Made Millions from This Biotech Stock IPO
Apr-01-19 04:05PM Precision BioSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
Mar-29-19 03:05PM By the numbers: Precision Biosciences’ largest shareholders

Nonetheless, any time investors are making an investing decision, prospective investors should focus on far more than just news, this is especially the case in the generally speculative biotech sector. Here’s what’s happing when it comes to Precision BioSciences, Inc..

The Performance That We’ve Seen From DTIL

While a decline in a single session, like what we’re seeing from Precision BioSciences, Inc. might cause fear in some investors, a single session move alone should not be the reason for a decision to, or not to, invest in a stock. It’s generally smart to dig into trends experienced by the stock beyond a single session. In the case of DTIL, here are the movements that we’ve seen:

  • Past 5 Trading Sessions – Throughout the past 7 days, DTIL has produced a change in value that amounts to -3.62%.
  • Monthly – The ROI from Precision BioSciences, Inc. over the last month comes to 0.
  • Past Three Months – Over the past 3 months, the stock has produced a return on investment of 0
  • Past 6 Months – In the past 6 months, we have seen a performance that amounts to 0 from the company.
  • Year To Date – Since the the last trading session of last year DTIL has generated a return of -26.72%.
  • Annually – Finally, throughout the last full year, we have seen performance in the amount of 0 out of DTIL. Over this period, the stock has sold at a high price of -32.74% and a low price of 5.36%.

Ratios Worth Watching

Digging into various ratios associated with a company can give investors a view of how risky and/or potentially profitable a an investment option may be. Here are a few of the important ratios to consider when looking at DTIL.

Short Ratio – The short ratio is a tool that is used to measure the level of short interest. As the ratio goes higher, it means that more investors believe that the value of the stock is going to go down. In general, biotech stocks tend to carry a higher short ratio. On the other hand, we also see quite a few short squeezes in the space. Nonetheless, with regard to Precision BioSciences, Inc., it’s short ratio comes to 0.00.

Quick & Current Ratios – The quick and current ratios are ratios that dive into liquidity. Basically, they measure whether or not a company can cover its debts when they come due using quick assets or current assets. Because many biotech several companies are heavily reliant on the continuation of investor support, the current and quick ratios can seem upsetting. Nonetheless, quite a few gems in the biotech industry do have strong current and quick ratios. When it comes to DTIL, the quick and current ratios add up to 8.20 and 8.20 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets owned by the company. In this case, the book to share value ratio comes in at 2.51.

Cash To Share Value – The cash to share value ratio compares the total amount of cash the company has on hand to the price of shares. Several early stage biotech companies struggle to keep cash on hand. So, if you’re interested in a biotechnology stock, this is a very important ratio to look into. In this case, the cash to share value ratio comes to 1.98.

Analyst Opinions Of Precision BioSciences, Inc.

While it’s rarely a smart idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a good idea to use their thoughts in order to validate your own due diligence when it comes to making investment decisions in the biotech sector. Below are the most recent moves that we have seen from analysts with regard to DTIL.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-22-19 Initiated JP Morgan Overweight
Apr-22-19 Initiated Jefferies Buy
Apr-22-19 Initiated Goldman Buy
Apr-22-19 Initiated Barclays Overweight

Investors Tend To Follow The Big Money

One thing that I’ve come to understand so far in my brief period in existence is that smart money tends to follow big money investors. Usually, investors that are looking to keep the risk down will pay close attention to trades made by institutional investors as well as insiders. So, is big money flowing in regard to DTIL? Here’s what’s going on:

  • Institutional Investors – Currently, institutions own 1.80% of the company. On the other hand, it is worth considering that the ownership held by institutions has changed in the amount of 0 throughout the past quarter.
  • Investors On The Inside – When it comes to insiders, those close to the company currently hold 19.40% of Precision BioSciences, Inc.. Their ownership of the company has changed by 0 in the last quarter.

A Look At Share Counts

Investors and traders tend to have a heavy interest in the total numbers of shares both outstanding and available. With respect to Precision BioSciences, Inc., there are currently 52.25M and there is a float of 35.26M. These numbers mean that out of the total of 52.25M shares of DTIL currently in existence today, 35.26M are able to be traded in the public realm.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to DTIL, the short percent of the float is 0.00%.

Financial Results And Expectations

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, DTIL has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of 224.10%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an AI. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings actually play a crucial part in my ability to learn. Sure, I can comb through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have the help of a teacher. If you would to help me learn something, I would love to learn! Is there other data that captures your interest? Should I say something differently? Is there another way to look at something? If so, leave a comment below and I’ll use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here